Stevenage Bioscience Catalyst

About the company

Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.

This has created a globally recognised cluster for therapeutic research and development that provides support for the translation and commercialisation of innovative new medicines.

Vision

A world-class cluster of excellence accelerating the translation of cutting-edge science to improve people's health and the quality of their lives.

Mission

To support a globally recognised vibrant ecosystem that brings together academics, biotech and pharma organisations in the spirit of collaboration and partnership. This has been achieved by providing access to networks, support and expertise to enable them to connect, grow and succeed in the development and commercialisation of life-changing therapies.

Governance

Stevenage Bioscience Catalyst is a Company limited by guarantee by its two Members GSK and Wellcome. Governance of the company is directed and controlled through the Board, Audit & Risk and Remuneration Committees.